Industrial Impact, Medical

Producing therapeutic peptides using biotechnology

October 20, 2022

Producing therapeutic
We began the project by working to the design of a recombinant bacterial strain selection of a strain capable
of producing high concentrations of peptides.

Spotlight

StatRad

Built from the ground up by physicians for physicians, StatRad has been passionately dedicated to providing the very best in patient care while constantly improving our service to our partners through the latest advances in technology. Established in 1996, we partnered with local radiology groups to provide coverage after normal business hours. In 2001, we introduced an innovative teleradiology platform to accelerate transmissions, streamline workflows, increase productivity and improve communication among physicians. Today, we’re maintaining our pioneering spirit by introducing new innovations to the market on a regular basis and providing the technology, expertise and service to help our clients deliver excellent care.

OTHER WHITEPAPERS
news image

Accelerating the Biomanufacturing Revolution

whitePaper | February 11, 2022

The biomanufacturing revolution is here. Recent advancements in the field of synthetic biology have enabled significant cost reductions in foundational bioengineering unit operations such as DNA synthesis and sequencing.

Read More
news image

Your Ultimate Guide to CMC Testing Support for Gene and Cell Therapy

whitePaper | December 6, 2022

The development of Advanced Therapy Medicinal Products such as gene and cell therapy products, has made significant progress in the treatment of many diseases, including cancer, genetic, and autoimmune disorders.

Read More
news image

Impurity profiling and analysis of TheraPure GMP nucleotides

whitePaper | March 22, 2023

Nucleoside triphosphates (NTPs) are key building blocks of many nucleic acid therapeutics and vaccines. These molecules are a vital component of revolutionary new medicines.

Read More
news image

THE RNA PLATFORM

whitePaper | May 26, 2022

Exploring biomarkers with the new central dogma. It can be a daunting decision for scientists to know when to focus on DNA, messenger RNA (mRNA), non-coding RNA (ncRNA) or protein biomarkers for routine clinical use, with each exhibiting its own strengths and limitations

Read More
news image

The EU Clinical Trials Regulation − What You Need to Know

whitePaper | March 22, 2022

The Clinical Trials Regulation has retained some definitions and refined others. For example the definition of “clinical study”: “Any investigation in relation to humans intended: (a) to discover or verify the clinical, pharmacological or other pharmacodynamic.

Read More
news image

U.S. Biopharma Expansions to Europe: Ensuring Successful Build-Out & Market Access

whitePaper | May 24, 2023

The Greater Zurich Area Ltd (GZA), Apellis, and Korn Ferry co-hosted a virtual roundtable for a select group of biopharma leaders interested in expanding their operations into Europe. The panel brought together European launch specialists, talent experts, and Swiss government officials to cover critical questions and guiding principles necessary for a successful European launch, as well as insider knowledge of how to best navigate the regulatory environment.

Read More

Spotlight

StatRad

Built from the ground up by physicians for physicians, StatRad has been passionately dedicated to providing the very best in patient care while constantly improving our service to our partners through the latest advances in technology. Established in 1996, we partnered with local radiology groups to provide coverage after normal business hours. In 2001, we introduced an innovative teleradiology platform to accelerate transmissions, streamline workflows, increase productivity and improve communication among physicians. Today, we’re maintaining our pioneering spirit by introducing new innovations to the market on a regular basis and providing the technology, expertise and service to help our clients deliver excellent care.

Events